Archean Chemical Industries Limited

BSE: ACI543657ISIN INE128X01021

Commodities
Specialty Chemicals
BSE 1000

Share price

₹428.60-11.50 (-2.61%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹660.80
52W low: ₹427.30
Off 52W high: -35.14%
1M return: -7.49%
3M return: -18.21%
6M return: -31.03%
1Y return: -34.05%
20D avg volume: 58,207
50 DMA: ₹474.08
200 DMA: ₹536.51

Key ratios Consolidated

Market cap: ₹5,291 Cr
Current price: ₹428.60
52W high / low: ₹660.80 / ₹427.30
Face value: ₹2.00
P/E: 54.04
P/B: 2.70
EPS (TTM): ₹7.93
Book value / share: ₹159.02
ROE: —
ROCE: 7.80%
Operating margin: —
Net margin: —
Debt / equity: 0.24
Net debt: ₹425.15 Cr
Interest cover: 6.71
Dividend yield: 0.58%
Dividend / share (TTM): ₹2.50
Payout: 31.53%
Cash conversion cycle: 80.1 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	297.36	327.20	300.94	254.56	233.18	292.36	345.58	242.29	240.46	212.69	283.90	412.63
	4.25	5.61	5.39	6.95	6.38	8.23	7.81	8.85	10.92	9.70	11.96	9.24
	301.61	332.81	306.33	261.52	239.56	300.59	353.38	251.15	251.38	222.40	295.87	421.87
	255.88	288.59	290.48	228.19	199.66	242.58	278.71	185.40	188.41	161.84	216.15	286.74
	44.12	38.50	25.52	15.43	12.67	34.06	22.87	11.68	14.76	13.63	12.19	9.94
	0.00	0.00	0.00	0.00	0.00	16.52	0.00	—	—	—	—	—
	19.41	19.30	21.30	17.30	16.85	18.73	19.59	13.90	12.84	14.72	14.67	18.22
	4.87	5.45	10.43	4.42	5.52	5.38	0.29	2.90	3.21	1.70	1.70	1.90
	23.86	23.20	22.80	23.60	23.55	22.94	21.14	20.14	19.46	18.64	17.67	17.66
	185.23	210.03	196.67	183.80	153.60	169.74	225.34	164.25	139.21	144.81	190.02	202.01
	45.73	44.22	15.86	33.33	39.91	58.01	74.67	65.75	62.97	60.56	79.72	135.13
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-40.18	0.00	0.00	0.00
	45.73	44.22	15.86	33.33	39.91	58.01	74.67	65.75	22.79	60.56	79.72	135.13
	14.40	13.87	3.63	9.33	10.87	17.86	20.93	17.93	7.05	15.72	22.13	33.60
	31.33	30.35	12.23	24.00	29.04	40.14	53.75	47.82	15.73	44.84	57.59	101.53
	2.60	2.48	1.13	1.92	2.36	3.25	4.33	3.89	1.28	3.64	4.65	8.24
Key metrics
	74.46	72.87	49.09	61.35	68.98	86.33	96.10	88.79	45.46	80.90	99.09	154.69
	25.00%	22.30%	16.30%	24.10%	29.60%	29.50%	27.80%	36.60%	18.90%	38.00%	34.90%	37.50%
	10.50%	9.30%	4.10%	9.40%	12.50%	13.70%	15.60%	19.70%	6.50%	21.10%	20.30%	24.60%
	2.20%	—	1.20%	—	2.00%	—	3.40%	—	—	—	—	—
	27.50%	11.90%	-12.90%	5.10%	-3.00%	37.50%	21.70%	-41.30%	—	—	—	—
	7.90%	-24.40%	-77.20%	-49.80%	84.60%	-10.50%	-6.70%	-52.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	1,180	1,081	1,041	1,330	1,441
	22.20	26.95	37.28	43.32	43.27
	1,202	1,108	1,078	1,373	1,484
	1,063	960.90	814.35	946.23	972.66
	123.57	87.68	62.94	47.59	45.70
	0.00	16.52	0.00	—	4.43
	77.31	74.19	61.05	72.43	72.05
	25.17	25.75	8.10	8.46	96.96
	93.46	92.89	79.39	70.34	68.63
	775.73	703.81	673.60	707.33	732.29
	139.14	147.10	263.95	427.18	511.68
	0.00	0.00	-40.18	0.00	0.00
	139.14	147.10	223.77	427.18	511.68
	41.23	41.69	61.62	108.21	129.12
	97.91	105.41	162.15	318.97	382.56
	8.13	8.66	13.13	25.90	34.66
Key metrics
	257.77	265.74	311.26	505.98	677.27
	21.84%	24.60%	29.90%	38.00%	47.00%
	8.30%	9.80%	15.60%	24.00%	26.50%
	—	7.80%	10.60%	—	—
	5.99%	3.80%	-21.70%	-7.70%	—
	-42.66%	-35.00%	-49.20%	-16.60%	—
	—	-242.53	-87.34	—	—
	—	1.32	1.09	—	—
	—	0.24	0.10	—	—
	—	425.15	137.52	—	—
	—	80.1	79.8	—	—
Balance sheet
	—	2,665	2,393	—	—
	—	531.38	691.39	—	—
	—	41.23	40.54	—	—
	—	127.28	164.57	—	—
	—	214.92	168.13	—	—
	—	114.31	82.03	—	—
	—	1,383	1,378	—	—
	—	105.23	105.05	—	—
	—	438.35	197.28	—	—
	—	466.38	178.06	—	—
	—	294.70	26.46	—	—
	—	171.68	151.60	—	—
	—	1,933	1,864	—	—
Cash flow
	—	139.63	176.23	—	—
	—	-292.85	-246.23	—	—
	—	153.91	64.98	—	—
	—	382.16	263.57	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	290.72	315.93	292.28	249.87	220.76	278.63	321.77	242.54	238.31	211.16	283.39	412.63
	14.64	16.14	12.42	10.94	11.02	12.82	11.56	12.13	13.73	12.23	13.83	10.09
	305.36	332.07	304.71	260.81	231.78	291.45	333.33	254.66	252.05	223.40	297.22	422.72
	245.90	276.76	262.80	215.06	180.68	219.94	253.75	179.18	182.27	158.29	214.93	286.79
	41.67	30.69	17.13	10.64	10.38	14.45	7.72	7.28	11.46	12.42	11.45	9.94
	0.00	0.00	0.00	0.00	0.00	16.52	0.00	—	—	—	—	—
	16.05	16.20	16.39	15.03	14.42	16.50	14.47	13.06	12.33	14.07	14.57	18.21
	9.31	8.64	5.02	3.74	4.50	4.46	2.91	2.29	2.04	1.87	2.17	2.44
	20.53	19.91	19.47	20.37	20.39	19.82	18.62	18.55	17.99	17.89	17.47	17.60
	179.45	206.30	189.45	180.37	150.35	166.36	223.21	160.64	138.22	143.74	189.23	201.58
	59.46	55.31	41.90	45.75	51.10	71.51	79.58	75.48	69.78	65.10	82.29	135.93
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	-40.18	—	—	—
	59.46	55.31	41.90	45.75	51.10	71.51	79.58	75.48	29.60	65.10	82.29	135.93
	16.27	14.79	12.14	11.45	12.64	19.66	21.27	19.20	7.73	16.64	22.66	33.74
	43.20	40.53	29.76	34.30	38.46	51.85	58.31	56.29	21.87	48.46	59.64	102.19
	3.50	3.28	2.41	2.78	3.12	4.20	4.72	4.56	1.77	3.93	4.83	8.30
Key metrics
	89.30	83.86	66.39	69.86	75.99	95.79	101.11	96.32	49.63	84.86	101.93	155.97
	30.70%	26.50%	22.70%	28.00%	34.40%	34.40%	31.40%	39.70%	20.80%	40.20%	36.00%	37.80%
	14.90%	12.80%	10.20%	13.70%	17.40%	18.60%	18.10%	23.20%	9.20%	22.90%	21.00%	24.80%
	2.90%	—	2.10%	—	2.60%	—	3.90%	—	—	—	—	—
	31.70%	13.40%	-9.20%	3.00%	-7.40%	32.00%	13.50%	-41.20%	—	—	—	—
	12.30%	-21.80%	-49.00%	-39.10%	75.90%	7.00%	-2.20%	-44.90%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23
Income statement
	1,149	1,042	1,014	1,330	1,441
	54.14	47.21	49.66	46.70	44.18
	1,203	1,089	1,063	1,376	1,485
	1,001	878.49	773.50	944.92	972.17
	100.13	52.60	38.88	46.85	45.70
	0.00	16.52	0.00	—	4.43
	63.67	62.35	53.93	72.32	72.02
	26.71	17.72	9.11	9.67	96.96
	80.28	80.06	73.06	70.00	68.51
	755.57	686.54	665.80	705.87	731.94
	202.42	210.26	289.95	431.36	513.08
	0.00	0.00	-40.18	—	—
	202.42	210.26	249.77	431.36	513.08
	54.65	55.89	64.84	109.02	129.43
	147.79	154.37	184.92	322.35	383.65
	11.97	12.51	14.98	26.17	34.76
Key metrics
	309.41	308.04	331.94	511.03	678.55
	26.93%	29.60%	32.70%	38.40%	47.10%
	12.86%	14.80%	18.20%	24.20%	26.60%
	—	10.20%	12.30%	—	—
	8.00%	2.70%	-23.80%	-7.70%	—
	-27.88%	-16.50%	-42.60%	-16.00%	—
	—	127.55	74.36	—	—
	—	1.22	0.91	—	—
	—	0.16	0.06	—	—
	—	298.16	71.80	—	—
	—	83.8	78.5	—	—
Balance sheet
	—	2,571	2,249	—	—
	—	464.43	651.58	—	—
	—	23.39	35.93	—	—
	—	135.85	171.95	—	—
	—	199.46	153.93	—	—
	—	72.14	60.11	—	—
	—	1,067	1,071	—	—
	—	96.03	107.74	—	—
	—	330.40	145.42	—	—
	—	321.55	107.73	—	—
	—	219.41	23.03	—	—
	—	102.14	84.70	—	—
	—	1,998	1,880	—	—
Cash flow
	—	189.04	169.15	—	—
	—	-339.48	-195.88	—	—
	—	137.90	18.78	—	—
	—	61.49	94.79	—	—

Compounded growth

Standalone

Sales CAGR 3Y: -10.26%
Sales CAGR 5Y: —
Profit CAGR 3Y: -26.17%
Profit CAGR 5Y: —
Sales YoY (TTM): +8.00%
Profit YoY (TTM): -27.88%

Consolidated

Sales CAGR 3Y: -9.14%
Sales CAGR 5Y: —
Profit CAGR 3Y: -34.93%
Profit CAGR 5Y: —
Sales YoY (TTM): +5.99%
Profit YoY (TTM): -42.66%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 53.43%

Quarter	September 2026	June 2026
Promoter %	53.43%	53.43%

Holder	Type	Holding	Previous	Change
Chemikas Speciality LLP	Promoter	30.53%	30.53%	0.00%
Pendurthi Ranjit	Promoter	22.90%	22.90%	0.00%
HDFC MUTUAL FUND - HDFC MULTI CAP FUND	Public	4.16%	3.00%	+1.16%
SBI SMALL CAP FUND	Public	3.51%	6.88%	-3.37%
DSP MULTI CAP FUND	Public	3.03%	—	—
GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO	Public	2.46%	2.46%	0.00%
ICICI PRUDENTIAL COMMODITIES FUND	Public	1.22%	—	—
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND	Public	1.11%	1.11%	0.00%
MAHINDRA MANULIFE EQUITY SAVINGS FUND	Public	1.09%	—	—
ICICI LOMBARD GENERAL INSURANCE COMPANY LTD	Public	1.06%	1.06%	0.00%
Pendurthi Ravi	Promoter	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Pidilite Industries Ltd.	1,53,494	1,507.00	56.47	28.50%	+16.83% TTM	+20.94% TTM	+3.57%
Gujarat Fluorochemicals Limited	50,673	4,612.90	75.63	10.10%	+20.33% TTM	-1.47% TTM	+25.63%
Navin Fluorine International Limited	45,075	8,785.00	49.50	18.70%	+45.68% TTM	+105.04% TTM	+45.12%
Deepak Nitrite Limited	21,559	1,580.65	20.29	10.80%	+23.80% TTM	+99.83% TTM	-9.73%
Aether Industries Limited	20,478	1,542.85	82.16	12.20%	+30.76% TTM	+28.03% TTM	+103.85%
Aarti Industries Ltd	16,311	449.65	27.46	8.50%	+39.85% TTM	+104.40% TTM	+16.66%
Fine Organic Industries Limited	15,720	5,127.35	38.71	20.20%	+12.92% TTM	+18.80% TTM	+16.19%
Atul Limited.	15,177	5,155.00	19.28	13.50%	+18.15% TTM	+40.10% TTM	-12.49%
Anupam Rasayan India Limited	13,029	1,144.40	57.92	7.50%	+51.76% TTM	+14.65% TTM	+6.58%
PRIVI SPECIALITY CHEMICALS LIMITED	12,825	3,283.30	34.73	25.10%	+17.54% TTM	+44.15% TTM	+10.09%
BASF India Ltd	12,812	2,959.95	21.44	13.10%	+13.35% TTM	+59.30% TTM	-33.46%
Sudeep Pharma Limited	12,657	1,120.60	67.10	24.20%	—	—	—
Vinati Organics Ltd.	10,334	996.85	25.09	17.70%	+10.98% TTM	-5.48% TTM	-39.90%
Elantas Beck India Ltd S	10,127	12,774.65	54.20	—	+18.86% TTM	+35.25% TTM	+29.29%
Jubilant Ingrevia Limited	8,957	562.35	25.55	10.80%	+15.41% TTM	+21.73% TTM	-18.43%
Alkyl Amines Chemicals Ltd. S	8,108	1,585.25	32.77	14.60%	+13.38% TTM	+35.83% TTM	-13.31%
Galaxy Surfactants Limited	8,048	2,269.80	22.75	12.70%	+27.05% TTM	+16.13% TTM	+0.01%
Clean Science and Technology Limited	6,979	656.60	29.92	19.20%	+4.51% TTM	-12.06% TTM	-33.34%
Neogen Chemicals Limited	6,815	2,268.40	168.60	6.80%	+26.66% TTM	+55.16% TTM	+54.05%
Fineotex Chemical Limited	6,221	53.42	41.98	16.20%	+91.44% TTM	+41.07% TTM	+84.27%
Balaji Amines Ltd.	5,738	1,770.80	23.80	10.20%	+20.91% TTM	+66.05% TTM	+26.00%
Archean Chemical Industries Limited	5,291	428.60	54.04	7.80%	+5.99% TTM	-42.66% TTM	-34.05%
Prasol Chemicals Limited	4,594	776.20	—	—	—	—	—
Laxmi Organic Industries Limited	4,501	161.95	35.81	4.40%	+5.47% TTM	+25.01% TTM	-17.12%
Foseco India Ltd S	4,494	5,962.25	57.00	—	+10.33% TTM	-3.71% TTM	+5.42%

Some figures use IPO-document inputs. Growth periods are shown per value; FY means annual.

Filings & corporate actions

Recent announcements

Earnings call recording3 Nov 2026 · Company Update / Analyst / Investor Meet
Presentation for the earnings call2 Nov 2026 · Company Update / Investor Presentation
Newspaper publication of un-audited financial results of the Company for the quarter and half year ended September 30, 202630 Oct 2026 · Company Update / Newspaper Publication
Allotment of shares under Company Employee Stock Option Plan 202229 Oct 2026 · Company Update / Allotment of ESOP / ESPS
Please find enclosed the Unaudited Financial Results for the quarter & half year ended September 30, 202629 Oct 2026 · Result / Financial Results
Please find enclosed the Board meeting Outcome 29.10.202629 Oct 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Schedule for Earnings Call28 Oct 2026 · Company Update / Analyst / Investor Meet
Credit Rating22 Oct 2026 · Company Update / Credit Rating
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Un-Audited ....22 Oct 2026 · Board Meeting / Board Meeting
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP15 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP15 Oct 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 201812 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Closure of Trading Window24 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 23, 2026 for Chemikas Speciality LLP23 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP9 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund5 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Earnings call Transcript7 Aug 2026 · Company Update / Earnings Call Transcript
Earnings Call Recording3 Aug 2026 · Company Update / Analyst / Investor Meet
Investor Presentation1 Aug 2026 · Company Update / Investor Presentation
Newspaper Publication of Financial Result31 Jul 2026 · Company Update / Newspaper Publication
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP31 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.30 Jul 2026 · Result / Financial Results
Outcome of the Board Meeting held on July 30, 2026 1. The Un-Audited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Pursuant to Regulation 33(3) of ....30 Jul 2026 · Board Meeting / Outcome of Board Meeting
Intimation of Schedule for Earnings Call28 Jul 2026 · Company Update / Analyst / Investor Meet
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2026 for Chemikas Speciality LLP24 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Reconciliation of share capital audit18 Jul 2026 · Company Update / General
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve un-audited Standalone ....18 Jul 2026 · Board Meeting / Board Meeting
Clarification on increase in the volume movement of Security across Exchanges16 Jul 2026 · Company Update / General
The Exchange has sought clarification from Archean Chemical Industries Ltd on July 16, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.16 Jul 2026 · Company Update / Clarification
General Update15 Jul 2026 · Company Update / General
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP13 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP13 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations6 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 04, 2026 for Chemikas Speciality LLP6 Jul 2026 · Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Intimation of order under Section 270A of the Income Tax Act, 19611 Jul 2026 · Company Update / General
Closure of Trading Window23 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd13 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Voting Results of 17th Annual General Meeting (AGM) of the Company along with Scrutinizer''s Report12 Jun 2026 · AGM/EGM / AGM
Re-appointment of M/s PKF Sridhar & Santhanam LLP, as the Statutory Auditor of the Company. Re-appointment of Mr. Kandheri Munuswamy Mohandass and Mr. Chittoor Ghatambu Sethuram as the ....12 Jun 2026 · Company Update / Change in Management
Proceedings of the 17th Annual General Meeting (AGM)12 Jun 2026 · AGM/EGM / AGM

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 2.5000	5 Jun 2026	5 Jun 2026	—
Final Dividend - Rs. - 3.0000	26 May 2025	26 May 2025	—

Board meetings

29 Oct 2026 Board Meeting - Financial Results
30 Jul 2026 Board Meeting - Financial Results